Press releases and News
2023-03-10 15:15
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION...
2023-03-09 15:30
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION...
2023-02-16 14:20
Senzime AB (publ) (”Senzime” or ”the Company”) announced on 23 February 2023 that the Board of Directors had resolved on a new issue of shares of approximately SEK 100 million with preferential right for existing shareholders (the...
2023-02-16 09:22
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 16 February 2023, whereby the shareholders primarily resolved on the following matter. Resolution on the approval of the board of...
2023-02-01 08:59
One of the leading pediatric hospitals in the US will implement Senzime’s quantitative neuromuscular monitoring system Uppsala, February 1, 2023. Senzime AB (publ) today announced that one of the leading pediatric hospitals in the US has decided...
2023-02-01 08:30
Press release: Uppsala, 01 February 2022. Senzime AB's (publ) interim report for January - December 2022 is now available on the company's website www.senzime.com. Financial information October - December 2022 Financial information January - December...
2023-01-23 19:19
Senzime AB (publ) (”Senzime” or the ”Company”) issues preliminary financial information for the fourth quarter 2022 with a general update of the Company’s financial and operational development and brings forward the announcement...
2023-01-23 19:17
The shareholders in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on Thursday 16 February 2023, at 08.30 at Advokatfirman Lindahl’s premises, Vaksalagatan 10, Uppsala...
2023-01-23 19:15
The Board of Directors of Senzime AB (publ) (“Senzime” or the “Company”) has today, 23 January 2023, resolved on a new issue of shares of approximately SEK 100 million with preferential rights for existing shareholders (the “Rights...
2022-11-15 10:00
Uppsala, November 15, 2022. Senzime AB (publ) will give an update at today’s investor event on the strategy following the acquisition of Respiratory Motion (RMI), present the growth opportunities in the market given the new US and European clinical...
